SANA logo
SANA NASDAQ US

Sana Biotechnology, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Feb 2021
$3.20
▲ +$0.15 (+4.92%)
Vol 3.3M
3
Quality Score
fail
Mkt Cap
$1.1B
ROE
-120.6%
D/E
0.00
Beta
1.98
52W
$1–$7

Wall Street Consensus

15 analysts · Apr 2026
6
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
86.7%
Buy Rating

Price Chart

Similar Stocks

ORIC
Oric Pharmaceuticals Inc
$796.6M
XNCR
Xencor Inc
$1.1B
ABUS
Arbutus Biopharma Corp
$925.1M
CGEM
Cullinan Therapeutics Inc
$611.4M
SPRY
ARS Pharmaceuticals Inc
$1.2B
ANNX
Annexon Inc
$726.5M
MNKD
MannKind Corp
P/E 60.5
$1.7B
JBIO
Jade Biosciences Inc
$709.8M

Earnings

Beat rate: 75.0%
Next Report May 06, 2026
EPS Estimate: $-0.17
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.17 — —
Dec 2025 $-0.14 $-0.21 $-0.07
Sep 2025 $-0.18 $-0.16 +$0.02
Jun 2025 $-0.21 $-0.21 +$0.00

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -115.3% -115.3% -115.3% -115.3% -120.6% -120.6%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.47 2.47 2.47 2.47 4.55 4.55

Key Ratios

ROA (TTM)
-53.8%
P/B
1.5
EPS (TTM)
$-0.97
CF/Share
$-1.33
52W High
$7.30
52W Low
$1.26
$1.26 52-Week Range $7.30

How does SANA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SANA AAPG ABEO ABOS ABP

SANA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.5
▼ 41% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SANA profitability vs Biotechnology peers

ROE
-120.6%
▼ 79% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-53.8%
▼ 15% below peers (-46.7%)
vs Peers
vs Industry
In line

SANA financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.6
▲ 3% above peers (4.4)
vs Peers
vs Industry
In line
Beta
2.0
▲ 105% above peers (1.0)
vs Peers
vs Industry
More volatile

SANA fundamentals radar

SANA Peer median Industry

SANA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SANA vs peers: key metrics

Latest News

Iraq Revives Syria Land Route, Post-Assad, To Export Oil To Europe
ZeroHedge · Apr 03